Terms: = Lung cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
18 results:
1. The role of hmga2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.
Qian S; Wang F; Liao W; Liu J
Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
[TBL] [Abstract] [Full Text] [Related]
3. CircRNA High Mobility Group At-hook 2 regulates cell proliferation, metastasis and glycolytic metabolism of nonsmall cell lung cancer by targeting miR-331-3p to upregulate High Mobility Group At-hook 2.
Li S; Zhao J; Wen S; Li M; Yu F; Wang W; Shao H; Jiang D
Anticancer Drugs; 2023 Jan; 34(1):81-91. PubMed ID: 36066399
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/hmga2 axis.
Li WJ; Li G; Liu ZW; Chen ZY; Pu R
Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
[TBL] [Abstract] [Full Text] [Related]
6. Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer.
Siddiqui MA; Gollavilli PN; Ramesh V; Parma B; Schwab A; Vazakidou ME; Natesan R; Saatci O; Rapa I; Bironzo P; Schuhwerk H; Asangani IA; Sahin O; Volante M; Ceppi P
Br J Cancer; 2021 Jan; 124(1):281-289. PubMed ID: 33024270
[TBL] [Abstract] [Full Text] [Related]
7. PP4R1 interacts with hmga2 to promote non-small-cell lung cancer migration and metastasis via activating MAPK/ERK-induced epithelial-mesenchymal transition.
Wang B; Pan LY; Kang N; Shen XY
Mol Carcinog; 2020 May; 59(5):467-477. PubMed ID: 32077156
[TBL] [Abstract] [Full Text] [Related]
8. The role of let-7 and hmga2 in the occurrence and development of lung cancer: a systematic review and meta-analysis.
Li XX; Di X; Cong S; Wang Y; Wang K
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8353-8366. PubMed ID: 30556876
[TBL] [Abstract] [Full Text] [Related]
9. Long non‑coding RNA DANCR promotes hmga2‑mediated invasion in lung adenocarcinoma cells.
Zhang N; Jiang W
Oncol Rep; 2019 Feb; 41(2):1083-1090. PubMed ID: 30535487
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.
Castiglione R; Alidousty C; Holz B; Wagener S; Baar T; Heydt C; Binot E; Zupp S; Kron A; Wolf J; Merkelbach-Bruse S; Reinhardt HC; Buettner R; Schultheis AM
Mod Pathol; 2019 May; 32(5):627-638. PubMed ID: 30459450
[TBL] [Abstract] [Full Text] [Related]
11. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract] [Full Text] [Related]
12. The role of Thyroid Transcription Factor-1 and Tumor differentiation in Resected lung Adenocarcinoma.
Huang TW; Lin KF; Lee CH; Chang H; Lee SC; Shieh YS
Sci Rep; 2017 Oct; 7(1):14222. PubMed ID: 29079814
[TBL] [Abstract] [Full Text] [Related]
13. RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.
Kopparam J; Chiffelle J; Angelino P; Piersigilli A; Zangger N; Delorenzi M; Meylan E
Cell Death Differ; 2017 Oct; 24(10):1761-1771. PubMed ID: 28574510
[TBL] [Abstract] [Full Text] [Related]
14. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
Lu B; Shi H; Zhang X
Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
[TBL] [Abstract] [Full Text] [Related]
15. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer.
Li XJ; Gangadaran P; Kalimuthu S; Oh JM; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC
Int J Cancer; 2016 Dec; 139(11):2583-92. PubMed ID: 27537102
[TBL] [Abstract] [Full Text] [Related]
16. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
Lee CT; Wu TT; Lohse CM; Zhang L
Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
[TBL] [Abstract] [Full Text] [Related]
17. hmga2 overexpression in non-small cell lung cancer.
Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
[TBL] [Abstract] [Full Text] [Related]
18. Increased expression of high mobility group A proteins in lung cancer.
Sarhadi VK; Wikman H; Salmenkivi K; Kuosma E; Sioris T; Salo J; Karjalainen A; Knuutila S; Anttila S
J Pathol; 2006 Jun; 209(2):206-12. PubMed ID: 16521118
[TBL] [Abstract] [Full Text] [Related]
